Author:
Kundu Namita,Ma Xinrong,Holt Dawn,Goloubeva Olga,Ostrand-Rosenberg Suzanne,Fulton Amy M.
Publisher
Springer Science and Business Media LLC
Reference52 articles.
1. Bennett A, Charlier EM, McDonald AM, Simpson JS, Stanford IF (1977) Prostaglandin and breast cancer. Lancet 2:624–626. doi: 10.1016/S0140-6736(77)92496-5
2. Ristimaki A, Sivula A, Lundin M et al (2002) Prognostic significance of elevated cyclooxygenase-2 expression in breast cancer. Cancer Res 62:632–635
3. Thun MJ, Namboodiri MM, Calle EE, Flanders WD, Heath CW Jr (1993) Aspirin use and risk of fatal cancer. Cancer Res 53:1322–1327
4. Harris RE, Beebe-Donk J, Alshafie GA (2006) Reduction of the risk of human breast cancer by selective cyclooxygenase-2 [COX-2] inhibitors. BMC Cancer 6:27–31. doi: 10.1186/1471-2407-6-27
5. Sheng H, Shao J, Morrow JD, Beauchamp RD, DuBois RN (1998) Modulation of apoptosis and Bcl-2 expression by prostaglandin E2 in human colon cancer cells. Cancer Res 58:362–366
Cited by
53 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献